Patents by Inventor Severin Jobert
Severin Jobert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 7413875Abstract: The sequences of 5? ESTs and consensus contigated 5?ESTs derived from mRNAs encoding secreted proteins are disclosed. The 5? ESTs and consensus contigated 5?ESTs may be to obtain cDNAs and genomic DNAs corresponding to the 5? ESTs and consensus contigated 5?ESTs. The 5? ESTs and consensus contigated 5?ESTs may also be used in diagnostic, forensic, gene therapy, and chromosome mapping procedures. Upstream regulatory sequences may also be obtained using the 5? ESTs and consensus contigated 5?ESTs. The 5? ESTs and consensus contigated 5?ESTs may also be used to design expression vectors and secretion vectors.Type: GrantFiled: September 15, 2003Date of Patent: August 19, 2008Assignee: Serono Genetics Institute S.A.Inventors: Jean-Baptiste Dumas Milne Edwards, Severin Jobert, Jean-Yves Giordano
-
Patent number: 7385034Abstract: The sequences of cDNAs encoding secreted proteins are disclosed. The cDNAs can be used to express secreted proteins or fragments thereof or to obtain antibodies capable of specifically binding to the secreted proteins. The cDNAs may also be used in diagnostic, forensic, gene therapy, and chromosome mapping procedures. The cDNAs may also be used to design expression vectors and secretion vectors.Type: GrantFiled: December 9, 2002Date of Patent: June 10, 2008Assignee: Serono Genetics Institute S.A.Inventors: Jean-Baptiste Dumas Milne Edwards, Lydie Bougueleret, Severin Jobert
-
Patent number: 7271243Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.Type: GrantFiled: August 19, 2003Date of Patent: September 18, 2007Assignee: Serono Genetics Institute S.A.Inventors: Jean-Baptiste Dumas Milne Edwards, Lydie Bougueleret, Severin Jobert
-
Patent number: 7223727Abstract: The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. GSSP4 polypeptides have been identified that are believed to be beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing cholesterol levels, body mass, body fat, and for treating metabolic-related diseases and disorders. The metabolic-related diseases or disorders include, but are not limited to, obesity, hyperlipidemia, hypercholesterolemia, atherosclerosis, diabetes, glucose intolerance, insulin resistance and hypertension.Type: GrantFiled: February 7, 2002Date of Patent: May 29, 2007Assignee: Serono Genetics Institute S.A.Inventors: Barbara Chicca, John Chicca, Blake Denison, Frances Yen-Potin, Bernard Bihain, Stephane Bejanin, Hiroaki Tanaka, Severin Jobert, Jean-Yves Giordano, Jean-Baptiste Dumas Milne Edwards
-
Publication number: 20070021597Abstract: The sequences of 5? ESTs and consensus contigated 5?ESTs derived from mRNAs encoding secreted proteins are disclosed. The 5? ESTs and consensus contigated 5?ESTs may be to obtain cDNAs and genomic DNAs corresponding to the 5? ESTs and consensus contigated 5?ESTs. The 5? ESTs and consensus contigated 5?ESTs may also be used in diagnostic, forensic, gene therapy, and chromosome mapping procedures. Upstream regulatory sequences may also be obtained using the 5? ESTs and consensus contigated 5?ESTs. The 5? ESTs and consensus contigated 5?ESTs may also be used to design expression vectors and secretion vectors.Type: ApplicationFiled: September 15, 2003Publication date: January 25, 2007Inventors: Jean-Baptiste Edwards, Severin Jobert, Jean-Yves Giordano
-
Publication number: 20060286639Abstract: The sequences of cDNAs encoding secreted proteins are disclosed. The cDNAs can be used to express secreted proteins or fragments thereof or to obtain antibodies capable of specifically binding to the secreted proteins. The cDNAs may also be used in diagnostic, forensic, gene therapy, and chromosome mapping procedures. The cDNAs may also be used to design expression vectors and secretion vectors.Type: ApplicationFiled: June 29, 2006Publication date: December 21, 2006Applicant: SERONO GENETICS INSTITUTE S.A.Inventors: Jean-Baptiste Dumas Milne Edwards, Lydie Bougueleret, Severin Jobert, Catherine Clusel, Aymeric Duclert
-
Publication number: 20060130160Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.Type: ApplicationFiled: August 4, 2005Publication date: June 15, 2006Applicant: Serono Genetics Institute S.A.Inventors: Jean-Baptiste Dumas Milne Edwards, Lydie Bougueleret, Severin Jobert
-
Patent number: 7060479Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.Type: GrantFiled: June 8, 2001Date of Patent: June 13, 2006Assignee: Serono Genetics Institute, S.A.Inventors: Jean-Baptiste Dumas Milne Edwards, Lydie Bougueleret, Severin Jobert
-
Publication number: 20060053498Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.Type: ApplicationFiled: April 18, 2001Publication date: March 9, 2006Inventors: Stephane Bejanin, Jean-Baptiste Dumas Milne Edwards, Jean-Yves Giordano, Severin Jobert, Hiroaki Tanaka
-
Publication number: 20060009633Abstract: The sequences of cDNAs encoding secreted proteins are disclosed. The cDNAs can be used to express secreted proteins or fragments thereof or to obtain antibodies capable of specifically binding to the secreted proteins. The cDNAs may also be used in diagnostic, forensic, gene therapy, and chromosome mapping procedures. The cDNAs may also be used to design expression vectors and secretion vectors.Type: ApplicationFiled: October 15, 2001Publication date: January 12, 2006Applicant: GENSET, S.A.Inventors: Jean-Baptiste Dumas Milne Edwards, Lydie Bougueleret, Severin Jobert, Catherine Clusel, Aymeric Duclert
-
Publication number: 20050096458Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.Type: ApplicationFiled: August 19, 2003Publication date: May 5, 2005Inventors: Jean-Baptiste Dumas Milne Edwards, Lydie Bougueleret, Severin Jobert
-
Publication number: 20050075285Abstract: The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. GSSP4 polypeptides have been identified that are believed to be beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing cholesterol levels, body mass, body fat, and for treating metabolic-related diseases and disorders. The metabolic-related diseases or disorders envisioned to be treated by the methods of the invention include, but are not limited to: obesity, hyperlipidemia, hypercholesterolemia, atherosclerosis, diabetes, glucose intolerance, insulin resistance and hypertension.Type: ApplicationFiled: February 7, 2002Publication date: April 7, 2005Inventors: Barbara Bour, John Chicca, Blake Denison, Frances Yen-Potin, Bernard Bihain, Stephane Bejanin, Hiroaki Tanaka, Severin Jobert, Jean-Yves Giordano, Jean-Baptiste Dumas Milne Edwards
-
Publication number: 20040110939Abstract: The sequences of cDNAs encoding secreted proteins are disclosed. The cDNAs can be used to express secreted proteins or fragments thereof or to obtain antibodies capable of specifically binding to the secreted proteins. The cDNAs may also be used in diagnostic, forensic, gene therapy, and chromosome mapping procedures. The cDNAs may also be used to design expression vectors and secretion vectors.Type: ApplicationFiled: October 15, 2001Publication date: June 10, 2004Applicant: GENSET, S.A.Inventors: Jean-Baptiste Dumas Milne Edwards, Lydie Bougueleret, Severin Jobert, Catherine Clusel, Aymeric Duclert
-
Publication number: 20030203377Abstract: The sequences of cDNAs encoding secreted proteins are disclosed. The cDNAs can be used to express secreted proteins or fragments thereof or to obtain antibodies capable of specifically binding to the secreted proteins. The cDNAs may also be used in diagnostic, forensic, gene therapy, and chromosome mapping procedures. The cDNAs may also be used to design expression vectors and secretion vectors.Type: ApplicationFiled: December 9, 2002Publication date: October 30, 2003Inventors: Jean-Baptiste Dumas Milne Edwards, Lydie Bougueleret, Severin Jobert
-
Patent number: 6639063Abstract: The sequences of 5′ ESTs and consensus contigated 5′ ESTs derived from mRNAs encoding secreted proteins are disclosed. The 5′ ESTs and consensus contigated 5′ ESTs may be used to obtain cDNAs and genomic DNAs corresponding to the 5′ ESTs and consensus contigated 5′ ESTs. The 5′ ESTs and consensus contigated 5′ ESTs may also be used in diagnostic, forensic, gene therapy, and chromosome mapping procedures. Upstream regulatory sequences may also be obtained using the 5′ ESTs and consensus contigated ESTs. The 5′ ESTs and consensus contigated 5′ ESTs may also be used to design expression vectors and secretion vectors.Type: GrantFiled: July 21, 2000Date of Patent: October 28, 2003Assignee: Genset S.A.Inventors: Jean-Baptiste Dumas Milne Edwards, Severin Jobert, Jean-Yves Giordano
-
Publication number: 20030152921Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.Type: ApplicationFiled: June 8, 2001Publication date: August 14, 2003Inventors: Jean-Baptiste Dumas Milne Edwards, Lydie Bougueleret, Severin Jobert
-
Patent number: 6548633Abstract: The sequences of cDNAs encoding secreted proteins are disclosed. The cDNAs can be used to express secreted proteins or fragments thereof or to obtain antibodies capable of specifically binding to the secreted proteins. The cDNAs may also be used in diagnostic, forensic, gene therapy, and chromosome mapping procedures. The cDNAs may also be used to design expression vectors and secretion vectors.Type: GrantFiled: June 21, 2000Date of Patent: April 15, 2003Assignee: Genset, S.A.Inventors: Jean-Baptiste Dumas Milne Edwards, Lydie Bougueleret, Severin Jobert
-
Publication number: 20020102604Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.Type: ApplicationFiled: December 7, 2000Publication date: August 1, 2002Inventors: Jean-Baptiste Dumas Milne Edwards, Lydie Bougueleret, Severin Jobert